An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register.

Prince, Femke H M; de Bekker-Grob, Esther W; Twilt, Marinka; van Rossum, Marion A J; Hoppenreijs, Esther P A H; ten Cate, Rebecca; Koopman-Keemink, Yvonne; Gorter, Simone L; Raat, Hein; van Suijlekom-Smit, Lisette W A

Prince, Femke H M; de Bekker-Grob, Esther W; Twilt, Marinka; van Rossum, Marion A J; Hoppenreijs, Esther P A H; ten Cate, Rebecca; Koopman-Keemink, Yvonne; Gorter, Simone L; Raat, Hein; van Suijlekom-Smit, Lisette W A.

Affiliation

Prince FH; Department of Paediatrics/ Paediatric Rheumatology, Room Sp-1546, Erasmus MC Sophia Children's Hospital, PO Box 2060, 3000 CB Rotterdam, The Netherlands. f.prince@erasmusmc.nl

Rheumatology (Oxford) ; 50(6): 1131-6, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21278067

Subject(s)

Antirheumatic Agents/economics; Arthritis, Juvenile/drug therapy; Arthritis, Juvenile/economics; Drug Costs; Immunoglobulin G/economics; Adolescent; Antirheumatic Agents/therapeutic use; Arthritis, Juvenile/diagnosis; Child; Cohort Studies; Cost of Illness; Cost-Benefit Analysis; Etanercept; Female; Health Care Costs; Humans; Immunoglobulin G/therapeutic use; Male; Netherlands; Receptors, Tumor Necrosis Factor/therapeutic use; Registries

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Juvenile / Immunoglobulin G / Drug Costs / Antirheumatic Agents Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google